Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Marfella

Showing results (241-250 of 306) with videos related to

Pageof 31
Sort By:
Antioxidants (Basel, Switzerland)|January 25, 2025
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle ModificationsAlfredo Caturano, Maria Rocco, Giuseppina Tagliaferri, et al.
Cardiovascular Diabetology|December 1, 2018
Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-upCelestino Sardu, Michelangela Barbieri, Maria Luisa Balestrieri, et al.
International Journal of Cardiology|July 24, 2013
Peri-procedural tight glycemic control during early percutaneous coronary intervention up-regulates endothelial progenitor cell level and differentiation during acute ST-elevation myocardial infarction: effects on myocardial salvageRaffaele Marfella, Maria Rosaria Rizzo, Mario Siniscalchi, et al.
Diabetes|October 18, 2014
Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatmentMaria Luisa Balestrieri, Maria Rosaria Rizzo, Michelangela Barbieri, et al.
Metabolism: Clinical and Experimental|November 21, 2021
Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic heartsRaffaele Marfella, Nunzia D'Onofrio, Maria Consiglia Trotta, et al.
Hypertension (Dallas, Tex. : 1979)|February 21, 2007
Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activityRaffaele Marfella, Mario Siniscalchi, Michele Portoghese, et al.
Cardiovascular Diabetology|January 6, 2024
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetesRaffaele Marfella, Francesco Prattichizzo, Celestino Sardu, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Cardiovascular Therapeutics at the Crossroads: Pharmacological, Genetic, and Digital FrontiersErica Vetrano, Alfredo Caturano, Davide Nilo, et al.
Frontiers in Pharmacology|June 5, 2024
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomesCelestino Sardu, Ludovica Vittoria Marfella, Valerio Giordano, et al.
International Journal of Molecular Sciences|February 25, 2023
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic OptionsRaffaele Galiero, Alfredo Caturano, Erica Vetrano, et al.
Pageof 31

Showing results (241-250 of 306) with videos related to

Sort By:
Pageof 31
Antioxidants (Basel, Switzerland)|January 25, 2025
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle ModificationsAlfredo Caturano, Maria Rocco, Giuseppina Tagliaferri, et al.
Cardiovascular Diabetology|December 1, 2018
Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-upCelestino Sardu, Michelangela Barbieri, Maria Luisa Balestrieri, et al.
International Journal of Cardiology|July 24, 2013
Peri-procedural tight glycemic control during early percutaneous coronary intervention up-regulates endothelial progenitor cell level and differentiation during acute ST-elevation myocardial infarction: effects on myocardial salvageRaffaele Marfella, Maria Rosaria Rizzo, Mario Siniscalchi, et al.
Diabetes|October 18, 2014
Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatmentMaria Luisa Balestrieri, Maria Rosaria Rizzo, Michelangela Barbieri, et al.
Metabolism: Clinical and Experimental|November 21, 2021
Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic heartsRaffaele Marfella, Nunzia D'Onofrio, Maria Consiglia Trotta, et al.
Hypertension (Dallas, Tex. : 1979)|February 21, 2007
Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activityRaffaele Marfella, Mario Siniscalchi, Michele Portoghese, et al.
Cardiovascular Diabetology|January 6, 2024
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetesRaffaele Marfella, Francesco Prattichizzo, Celestino Sardu, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Cardiovascular Therapeutics at the Crossroads: Pharmacological, Genetic, and Digital FrontiersErica Vetrano, Alfredo Caturano, Davide Nilo, et al.
Frontiers in Pharmacology|June 5, 2024
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomesCelestino Sardu, Ludovica Vittoria Marfella, Valerio Giordano, et al.
International Journal of Molecular Sciences|February 25, 2023
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic OptionsRaffaele Galiero, Alfredo Caturano, Erica Vetrano, et al.
Pageof 31